Oligonucleotide delivery in cancer therapy

Author： De Rosa Giuseppe   De Stefano Daniela   Galeone Aldo  

Publisher： Informa Healthcare

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.7, Iss.11, 2010-11, pp. : 1263-1278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy

By Gindy Marian E   Prud'homme Robert K  

Expert Opinion on Drug Delivery, Vol. 6, Iss. 8, 2009-08 ,pp. : 865-878

Informa Healthcare

Access to resources Recommend Favorite

Strategies to improve drug delivery in bladder cancer therapy

By Wirth M   Plattner VE   Gabor F  

Expert Opinion on Drug Delivery, Vol. 6, Iss. 7, 2009-07 ,pp. : 727-744

Informa Healthcare

Access to resources Recommend Favorite

Gene delivery and gene therapy of prostate cancer

By Kaliberov Sergey A   Buchsbaum Donald J  

Expert Opinion on Drug Delivery, Vol. 3, Iss. 1, 2006-01 ,pp. : 37-51

Informa Healthcare

Access to resources Recommend Favorite

Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy

By Simon Manuel   Stefan Nikolas   Plückthun Andreas   Zangemeister-Wittke Uwe  

Expert Opinion on Drug Delivery, Vol. 10, Iss. 4, 2013-04 ,pp. : 451-468

Informa Healthcare

Access to resources Recommend Favorite

Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool

By Kaneda Yasufumi  

Expert Opinion on Drug Delivery, Vol. 7, Iss. 9, 2010-09 ,pp. : 1079-1093

Informa Healthcare

Access to resources Recommend Favorite